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The role of necrotic and apoptotic pathways in cytolysis mediated by LAK cells was studied. The contribution of necrotic and apoptotic processes 
to cytolysis depends both on the LAK cells’ phenotype and the type of target cells. CD16+/CD8+/CD3- LAK cells induced necrosis of K562 and 
L929 target cells. The cell death induced by CD3+/CD8+/CD16- LAK cells was found to include features of apoptotic and necrotic processes. 
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1. INTRODUCTION 
Fts) = (ex~~rnen~ ~rn~~n~eous cpm) 
(total cpm-spontaneous cpm) 
x 100 
Two major processes in cell death are necrosis and 
apoptosis. Necrosis is characterized by rapid damage of 
the target cell membrane with subsequent colloid os- 
motic lysis, while the nucleus, at least in the early stages, 
remains intact. Apoptosis is characterized by DNA deg- 
radation into oligonucleosomal fragments in the early 
stages of the process, while the kinetics of the membrane 
damage is significantly slower [I]. 
3. RESULTS 
LAK cell activity was shown to be generated from 
phenotypically heterogeneous precursors: both T-cells 
[2] and NK [3] contribute to IL-Zgenerated cytotoxic 
activity. We examine here the role of the different path- 
ways of cell death (necrosis and apoptosis) in cytolysis 
mediated by different subsets of LAK cells. 
2. MATERIALS AND METHODS 
2.1. Ceil culturing 
Human LAK cells as well as L929 and K562 target cells were 
cultured as described in [4]. 
It was shown earlier [4,71 that the LAK cells’ pheno- 
type and their cytolytic activity changed during the 
course of IL-2 stimulation. In the first 4 days of IL-2 
stimulation the surface antigens characteristic for the 
NK cell phenotype (CD16+/CDS+/CD3-) were ex- 
pressed, then antigens characteristic for cytotoxic T- 
cells (CD3+/CD8+/CD16-) became predominant. We 
studied the mechanisms of target cell lysis induced by 
CD16+/CD8+ and CD3+/CD8+ LAK cells. The 
changes in the two parameters of cytolysis, i.e. plasma 
membrane permeability for Trypan blue dye (P) and 
DNA fragmentation (F}, were compared. The contribu- 
tion of necrotic and apoptotic processes to cytolysis was 
estimated by the P/F ratio. P/F c 1 was considered to 
be characteristic for apoptosis and P/F > 1 for necrotic 
processes [8]. 
2.2. Cytotoxicity and DNA fragmentation assay 
Membrane permeability (P) and DNA fragmentation (F) were de- 
termined as the percentage of Trypan blue that stained cells with 
damaged plasma membranes [5], and the percentage of specific release 
of degraded [SH]methylthymidine-labeled DNA [6], respectively, at a 
target/effecter ratio of 1120. 
@mined ells-s~n~neously stained cells) 
‘@) = (total cells-spontaneously stained cells) ’ loo 
*Co~~ponding author. 
Abbreviations: LAK cells, lymphokine-activated killer cells; IL-2, in- 
terleukin-2; NK, natural killer cells; CTL, cytotoxic T-lymphocytes; 
TNF, tumor necrosis factor. 
Fig. 1A shows the kinetics of K562 and L929 cell lysis 
by CD16+ LAK cells. Membrane damage was detected 
after 15 min of incubation and reached a maximum 
within 1 h, the kinetics of DNA fra~entation was 
significantly slower, since DNA fragments were de- 
tected after 1 h of cytolysis. These data indicated that 
CD16+ LAK cells caused mainly necrotic cell death 
(P/F = 2.5) of both K562 and L929 target cells. As seen 
in Fig. IB CD3+ LAK cells caused a complex process of 
cell death in K562 and L929 cells. DNA fragmentation 
(Fig. 1BI) was induced very rapidly (within 15 min) and 
reached a maximum at 3 h in K562 cells, then membrane 
permeability increased slowly and became maximal by 
4 h. Thus the first 3 h (P/F i: 1) were characteristic of 
apoptosis, but later, necrotic mechanisms (P/F = 1.3) 
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Fig. 1. Membrane permeability (filled circles) and DNA fragmentation (open circles) of KS62 (I) and L929 (II) target cells induced by CD16+/CD8+/ 
CD3- (A) and CD3+/CD8+/CD16- (B) LAK cells. 
became predominant. Fig. lBI1 demonstrates that 
CD3+ LAK cells induced necrosis in L929 cells (in 
contrast to K562 cells) in the early stages of cytolysis 
(P/F > I), and apoptosis (P/F = 0.7) in the later stages. 
4. DISCUSSION 
LAK cells differ in activation mechanisms, target spec- 
ificity and composition of proteins released [9, lo] so the 
mechanisms of target cell killing may also differ in LAK 
cell subsets [l 11. We have demonstrated that the contri- 
bution of apoptosis and necrosis to LAK cell lysis de- 
pends on the effector phenotype and the type of target 
cell. CD16+ LAK cells induced necrosis in K562 and 
L929 cells. At the same time both processes contributed 
to lysis mediated by CD3+ LAK cells, but the relative 
contribution of necrotic and apoptotic events were 
shown to be determined by target cell type. 
The diversity of cell death pathways is the result of 
several factors. Heterogeneity of target cells is due to 
tumor cell origin, oncogene activation and subsequent 
homeostatic change, characteristic of tumor cells, e.g. 
ability to react to proliferation and differentiation sig- 
nals, cell cycle stage, etc. [12,13]. These factors result in 
different sensitivities to lysis by potential cytolytic 
agents. At the same time cytolytic cells are known to 
express a wide spectrum of proteins which induce cytol- 
ysis [14] or participate indirectly in this process [15]. 
These cytolytic agents act through different receptor 
and second messenger systems, hence they differ in their 
specificity and mechanisms. Therefore cytolytic cell-me- 
diated cytolysis must be the result of a complex mix of 
influences of several cytolytic and regulatory factors, 
subsequently resulting in the disintegration via different 
pathways of cell homeostasis. 
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